Posted on Tuesday, April 15, 2014 at 11:28 am CDT
Global Markets Direct's, 'Jeil Pharmaceutical Co., Ltd. - Product Pipeline Review - 2014', provides an overview of the Jeil Pharmaceutical Co., Ltd.'s pharmaceutical research and development focus.
Source: Fast Market Research
Posted on Tuesday, April 15, 2014 at 11:10 am CDT
Global Markets Direct's, 'Botulism - Pipeline Review, H1 2014', provides an overview of the Botulism's therapeutic pipeline.
Source: Fast Market Research
Posted on Tuesday, April 15, 2014 at 10:41 am CDT
Global Markets Direct's, 'Lupin Limited - Product Pipeline Review - 2014', provides an overview of the Lupin Limited's pharmaceutical research and development focus.
Source: Fast Market Research
Posted on Tuesday, April 15, 2014 at 9:53 am CDT
Global Markets Direct's, 'Cholera - Pipeline Review, H1 2014', provides an overview of the Cholera's therapeutic pipeline.
Source: Fast Market Research
Posted on Tuesday, April 15, 2014 at 9:23 am CDT
Global Markets Direct's, 'Skin Inflammation - Pipeline Review, H1 2014', provides an overview of the Skin Inflammation's therapeutic pipeline.
Source: Fast Market Research
Posted on Tuesday, April 15, 2014 at 9:15 am CDT
Global Markets Direct's, 'Synta Pharmaceuticals Corp. - Product Pipeline Review - 2014', provides an overview of the Synta Pharmaceuticals Corp.'s pharmaceutical research and development focus.
Source: Fast Market Research
Posted on Tuesday, April 15, 2014 at 9:15 am CDT
Abraxis LLC, a supplier of rapid detection solutions to the $1 billion food pathogen market, announced that its non-O157 STEC Latex Agglutination Test (LAT) kits have been reviewed by the U.S. Department of Agriculture (USDA) and have been listed in the USDA Microbiological Laboratory Guidebook (MLG) as the LAT kits to be used in non-O157 STEC testing.
Source: Abraxis
Posted on Tuesday, April 15, 2014 at 9:07 am CDT
Global Markets Direct's, 'LFB S.A. - Product Pipeline Review - 2014', provides an overview of the LFB S.A.'s pharmaceutical research and development focus.
Source: Fast Market Research
Posted on Monday, April 14, 2014 at 9:30 am CDT
Global Markets Direct's, 'Mantle Cell Lymphoma - Pipeline Review, H1 2014', provides an overview of the Mantle Cell Lymphoma's therapeutic pipeline.
Source: Fast Market Research
Posted on Monday, April 14, 2014 at 9:30 am CDT
GlobalData's clinical trial report, "Penile Cancer Global Clinical Trials Review, H1, 2014" provides data on the Penile Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Penile Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Penile Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Source: Fast Market Research
Posted on Monday, April 14, 2014 at 9:30 am CDT
Global Markets Direct's, 'Biota Pharmaceuticals, Inc. - Product Pipeline Review - 2014', provides an overview of the Biota Pharmaceuticals, Inc.'s pharmaceutical research and development focus.
Source: Fast Market Research
Posted on Monday, April 14, 2014 at 9:15 am CDT
Global Markets Direct's, 'Endometrial Cancer - Pipeline Review, H1 2014', provides an overview of the Endometrial Cancer's therapeutic pipeline.
Source: Fast Market Research
Posted on Monday, April 14, 2014 at 9:15 am CDT
Global Markets Direct's, 'Essential Thrombocythemia - Pipeline Review, H1 2014', provides an overview of the Essential Thrombocythemia's therapeutic pipeline.
Source: Fast Market Research
Posted on Monday, April 14, 2014 at 9:15 am CDT
Global Markets Direct's, 'Myelodysplastic Syndrome - Pipeline Review, H1 2014', provides an overview of the Myelodysplastic Syndrome's therapeutic pipeline.
Source: Fast Market Research
Posted on Monday, April 14, 2014 at 9:15 am CDT
Global Markets Direct's, 'Arteriosclerosis - Pipeline Review, H1 2014', provides an overview of the Arteriosclerosis's therapeutic pipeline.
Source: Fast Market Research
Posted on Monday, April 14, 2014 at 9:15 am CDT
Global Markets Direct's, 'Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2014', provides an overview of the Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer's therapeutic pipeline.
Source: Fast Market Research
Posted on Monday, April 14, 2014 at 9:15 am CDT
Global Markets Direct's, 'Ewing Sarcoma - Pipeline Review, H1 2014', provides an overview of the Ewing Sarcoma's therapeutic pipeline.
Source: Fast Market Research
Posted on Monday, April 14, 2014 at 9:15 am CDT
Global Markets Direct's, 'Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H1 2014', provides an overview of the Chronic Obstructive Pulmonary Disease (COPD)'s therapeutic pipeline.
Source: Fast Market Research
Posted on Monday, April 14, 2014 at 9:15 am CDT
Global Markets Direct's, 'Kidney Fibrosis - Pipeline Review, H1 2014', provides an overview of the Kidney Fibrosis's therapeutic pipeline.
Source: Fast Market Research
Posted on Monday, April 14, 2014 at 9:00 am CDT
Global Markets Direct's, 'Stroke - Pipeline Review, H1 2014', provides an overview of the Stroke's therapeutic pipeline.
Source: Fast Market Research
Posted on Monday, April 14, 2014 at 9:00 am CDT
Global Markets Direct's, 'Schizophrenia - Pipeline Review, H1 2014', provides an overview of the Schizophrenia's therapeutic pipeline.
Source: Fast Market Research
Posted on Monday, April 14, 2014 at 9:00 am CDT
Global Markets Direct's, 'Urigen Pharmaceuticals, Inc. - Product Pipeline Review - 2014', provides an overview of the Urigen Pharmaceuticals, Inc.'s pharmaceutical research and development focus.
Source: Fast Market Research
Posted on Monday, April 14, 2014 at 9:00 am CDT
Global Markets Direct's, 'Respiratory Depression - Pipeline Review, H1 2014', provides an overview of the Respiratory Depression's therapeutic pipeline.
Source: Fast Market Research
Posted on Monday, April 14, 2014 at 9:00 am CDT
Global Markets Direct's, 'Neuro Endocrine (Carcinoid) Carcinoma - Pipeline Review, H1 2014', provides an overview of the Neuro Endocrine (Carcinoid) Carcinoma's therapeutic pipeline.
Source: Fast Market Research
Posted on Monday, April 14, 2014 at 9:00 am CDT
Global Markets Direct's, 'Malignant Mesothelioma - Pipeline Review, H1 2014', provides an overview of the Malignant Mesothelioma's therapeutic pipeline.
Source: Fast Market Research